Gulf Coast UTI Study Reveals Understudied Bacterial Threat With Antibiotic Resistance

Researchers at the University of South Alabama have identified a bacterial threat that has been quietly circulating in Gulf Coast hospitals and clinics, largely unnoticed by the broader medical community. The bacterium, Pseudomonas aeruginosa, is responsible for roughly twice as many urinary tract infections in the region as it is nationally—about 4 percent of local cases compared to the expected 2 percent. The findings, published in the American Society for Microbiology's journal mSphere, reveal not just a regional prevalence problem, but a collection of genetic variants and antibiotic resistance patterns that complicate treatment.

Most urinary tract infections are caused by E. coli, a pathogen that has been studied extensively. Pseudomonas aeruginosa, by contrast, has received comparatively little attention in the context of urinary infections. What researchers do know about the bacterium comes largely from studies of lung and wound infections—environments that behave very differently from the urinary tract. Allyson Shea, an assistant professor of microbiology and immunology at the Frederick P. Whiddon College of Medicine, led the investigation with Rachel Fleck, a first-year medical student, as first author. Their goal was straightforward: to understand the genetic makeup and disease-causing properties of the urinary strains specifically, rather than relying on knowledge borrowed from other infection types.

The team examined 55 bacterial samples taken from patients with active infections. What they discovered was striking genetic diversity. Many of the strains circulating among Gulf Coast patients did not match any previously documented genetic sequences. This suggests that Pseudomonas aeruginosa in the urinary tract is far more varied than current medical literature acknowledges. The researchers also found that certain strains appeared more frequently in specific patient populations—one variant showed up more often in people with urinary catheters, while another was linked to diabetic patients. These associations hint at how the bacterium may exploit particular vulnerabilities.

The antibiotic resistance findings are perhaps the most clinically urgent. Nearly one-third of the isolates tested showed resistance to levofloxacin, a fluoroquinolone antibiotic commonly prescribed for urinary infections. Several strains were resistant to multiple antibiotics simultaneously, narrowing treatment options and making infections harder to clear. For patients and clinicians, this means that standard first-line therapies may fail, requiring more aggressive or less convenient alternatives.

Yet the most pressing unanswered question remains: why is Pseudomonas aeruginosa so much more prevalent along the Gulf Coast? Shea acknowledged that the research team does not yet know. The explanation is likely complex—climate, the specific composition of the patient population, healthcare-associated exposures, and underlying health conditions may all play a role. Answering that question would require larger epidemiologic studies that track the bacterium across multiple regions and healthcare systems over time.

The immediate impact on patient care is limited. Doctors are not being asked to change how they diagnose or treat urinary infections based on these findings. But Shea framed the work as foundational. By mapping the genetic and phenotypic diversity of Pseudomonas aeruginosa strains in the urinary tract, researchers have created a baseline for future investigation. Understanding how these infections develop and persist in the urinary environment is the necessary first step toward developing targeted treatments or prevention strategies. For now, the study serves as a quiet alarm: a pathogen that has been overlooked is more common and more complex than previously recognized, and the medical field has much more to learn.